Old Web
English
Sign In
Acemap
>
authorDetail
>
Atagi S
Atagi S
Medicine
Docetaxel
General surgery
Combination therapy
Lung cancer
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd - generation EGFR-TKI-refractory NSCLC
2021
Tamiya M
Tamiya A
Norio Okamoto
Y. Taniguchi
Kazumi Nishino
Atagi S
Hirashima T
F Imamura
Toru Kumagai
Hidekazu Suzuki
Show All
Source
Cite
Save
Citations (0)
Efficacy and Safety of Carboplatin With Nab-Paclitaxel Versus Docetaxel in Elderly Patients with Squamous-Cell Lung Cancer (CAPITAL): A Randomized, Multicenter, Open-Label, Phase III Trial
2021
Social Science Research Network
Y. Kogure
Shunichiro Iwasawa
Hideo Saka
Hamamoto Y
A. Kada
Hiroya Hashimoto
Atagi S
Yasuo Takiguchi
Ebi N
Akihisa Inoue
Takayasu Kurata
Isamu Okamoto
Masafumi Yamaguchi
Harada T
Masahiro Seike
Takeharu Yamanaka
M. Ando
Saito Am
Kaoru Kubota
M. Takenoyama
Takashi Seto
Nobuyuki Yamamoto
Akihiko Gemma
Show All
Source
Cite
Save
Citations (0)
[Combination therapy with S-1 plus docetaxel (DOC) for previously treated patients with non-small cell lung cancer].
2006
Gan to kagaku ryoho. Cancer & chemotherapy
Atagi S
Show All
Source
Cite
Save
Citations (0)
1